Clinical Trials · NCT03262610
Setmelanotide in a Single Patient With Partial Lipodystrophy
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Rhythm Pharmaceuticals, Inc.
- Enrollment
- 1
- Start date
- Aug 2017
- Locations
- 1 site, United States
- Primary endpoint
- Fasting Triglycerides (TG) levels